Skip to content

Press

BLV-Press Releases
Bioluminescence Ventures Emerges from Stealth with $477M AUM
November 1, 2023 Nov 1, 2023
Portfolio-Media Coverage
ReCode raises $50 million to support developing mRNA therapies
September 22, 2023 Sep 22, 2023 Cystic Fibrosis News Today
Portfolio-Media Coverage
ReCode Raises $260M in Series B Financing to Advance Lead Programs
September 20, 2023 Sep 20, 2023 Biospace
Portfolio-Media Coverage
ReCode raises another $50M
September 19, 2023 Sep 19, 2023 Endpoints
Portfolio-Press Releases
ReCode Therapeutics Announces Closing of Extension to Series B Financing
September 19, 2023 Sep 19, 2023
Portfolio-Media Coverage
ReCode Therapeutics Raises Additional USD50M in Series B Financing
September 19, 2023 Sep 19, 2023 FinSMEs
Portfolio-Media Coverage
NIDO-361 by Nido Biosciences for Kennedy’s Disease (Spinal and Bulbar Muscular Atrophy): Likelihood of Approval
September 11, 2023 Sep 11, 2023 Pharmaceutical Technology
Portfolio-Media Coverage
Resiquimod by SURGE Therapeutics for Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer): Likelihood of Approval
September 11, 2023 Sep 11, 2023 Pharmaceutical Technology
Portfolio-Media Coverage
Companies To Watch: Nido Biosciences
September 1, 2023 Sep 1, 2023 Life Sciences Leader
Portfolio-Media Coverage
Surge receives $32 million in series B
July 23, 2023 Jul 23, 2023 Chemical & Engineering News